Navigation Links
Study Points to Molecular Origins of Celiac Disease
Date:7/21/2010

By Melissa Lee Phillips
HealthDay Reporter

WEDNESDAY, July 21 (HealthDay News) -- Scientists believe they've identified the molecular triggers of celiac disease, a finding they say could lead to the first drugs to tame the chronic, painful gut disorder.

People with celiac disease are intolerant to the protein gluten, which is found in wheat, barley and rye. Consuming these foods triggers an immune reaction that damages the lining of the small intestine, which can prevent the body from absorbing essential vitamins and nutrients.

Currently, the only treatment for celiac disease is adoption of a gluten-free diet, which means avoiding many types of bread, pasta, cereal and other foods. But gluten contamination in many foods makes it difficult to avoid and leads to long-lasting intestinal damage in some patients, said study senior author Robert Anderson, head of the celiac disease research laboratory at the Walter and Eliza Hall Institute of Medical Research in Parkville, Australia.

Regulating the aberrant immune response to gluten with a drug "would be a much more efficient way of dealing with celiac disease," Anderson said, but an incomplete understanding of how the immune system responds to gluten has prevented researchers from developing such therapies.

Gluten actually consists of many different protein components, and it's been unclear which of these fragments induces the immune response seen in celiac disease.

"You can't design drugs for celiac disease until you know the parts of the gluten that are driving the condition," Anderson explained.

During their investigation, he and his colleagues analyzed immune responses in the blood of more than 200 celiac disease patients after they had consumed meals containing gluten.

The researchers screened the blood samples for responses to thousands of different protein fragments (peptides) found in gluten, and they found that the patients' immune
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Puts Partial Hold on Avandia Safety Study
2. Not Every ACL Tear Needs Early Surgery, Study Suggests
3. Most men in long-term study of HIV report low use of illicit drugs
4. Gladstone and Lundbeck collaborate to study neurovascular disease
5. New Study Finds HPV Vaccine Protects Against Genital Warts
6. Vaginal Gel Cuts Risk of HIV Infection, Study Shows
7. Research consortium at CHLA receives $410,000 to study leukemia and lymphoma
8. Concordia researcher leads study that finds kids reduce physical activity for heart patients
9. Study Suggests Higher Cancer Rate Among IVF Babies
10. HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study
11. Anthony S. Fauci, M.D., on results from the CAPRISA 004 microbicide study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Points to Molecular Origins of Celiac Disease
(Date:8/29/2015)... AZ (PRWEB) , ... August 30, 2015 , ... ... David O’Shea to serve as the college’s Vice President of Strategic Initiatives and Information ... is eager to help the college expand its reach and impact through innovative technologies ...
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , ... standard shipping costs. , “Before, a threshold of $49.00 was required to qualify for ... items qualify for free standard shipping for customers regardless of the item’s selling price.” ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a ... products, today,announced that it has entered into definitive ... of 8,750,000 shares of,its common stock at $2.40 ... purchase 3,500,000 shares of common stock at an,exercise ...
... Respectively, Over Prior Year ... Period-, EXTON, Pa., ... for its second quarter and six,months of fiscal year 2008., Second Quarter ... income, increased 14% to $19.6 million in the Company,s second,fiscal quarter ended December ...
... Matthew L. Myers ... Tobacco-Free Kids, WASHINGTON, Jan. 24 The following statement,was ... A new global survey released by the U.S. Centers ... use, and even higher,rates of exposure to secondhand smoke, among ...
... 24 Karen Ignagni, President,and CEO of ... statement on,the Institute of Medicine,s (IOM) recommendation ... the effectiveness of healthcare products and,services:, ... deserve to know not only what medical ...
... day low price philosophy helps customers save more ... compared to prescription retail price, BENTONVILLE, Ark., ... recent prescription to over-the-counter (OTC) approved,drug, Zyrtec(R) (cetirizine ... Wal-Mart will offer eight different OTC Zyrtec products, ...
... Department of,Health and Human Services (HHS) Secretary ... standards developed by the Healthcare Information,Technology Standards ... advanced three,of its "Interoperability Specifications" to help ... a Nationwide Health Information Network in,the United ...
Cached Medicine News:Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 3Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 4Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 2Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 3Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 4Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 5Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 6Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 7Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 8Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 9Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 10Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 11Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 12Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 13Health News:New CDC Global Survey Finds Tobacco Taking Massive Toll on World's Children 2Health News:New CDC Global Survey Finds Tobacco Taking Massive Toll on World's Children 3Health News:Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec 2Health News:Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 4
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... company at the Bank of America Merrill Lynch Healthcare conference in ... Las Vegas, NV Presentation date: Tuesday May 10, 2011 ... A live webcast and 30-day archive of this presentation ...
... MELVILLE, N.Y., May 3, 2011 Henry Schein, ... healthcare products and services to office-based practitioners, today reported record ... Net sales for the first quarter of 2011 were ... quarter of 2010.  This consists of 9.9% growth in local ...
Cached Medicine Technology:Henry Schein Reports Record First Quarter Results 2Henry Schein Reports Record First Quarter Results 3Henry Schein Reports Record First Quarter Results 4Henry Schein Reports Record First Quarter Results 5Henry Schein Reports Record First Quarter Results 6Henry Schein Reports Record First Quarter Results 7Henry Schein Reports Record First Quarter Results 8Henry Schein Reports Record First Quarter Results 9
Colloidal Gold Conjugated, Protein A - 12 OD...
Colloidal Gold Conjugated, Protein G - 12 OD...
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: